We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-1.74%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$2.74B
AUM Growth
+$339M
Cap. Flow
-$310M
Cap. Flow %
-11.3%
Top 10 Hldgs %
45.15%
Holding
404
New
120
Increased
93
Reduced
80
Closed
88

Top Buys

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$23.4M
2
XOM icon
ExxonMobil
XOM
+$15.3M
3
PXD
Pioneer Natural Resource Co.
PXD
+$12.1M
4
MRK icon
Merck
MRK
+$9.03M
5
BPMC
Blueprint Medicines
BPMC
+$8.62M

Top Sells

Rank Stock Value
1
TPST icon
Tempest Therapeutics
TPST
+$53.9M
2
AGN
Allergan plc
AGN
+$33.8M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$24.7M
4
MBLY
Mobileye N.V.
MBLY
+$7.21M
5
MNKD icon
MannKind Corp
MNKD
+$5.7M

Sector Composition

Rank Sector Weight
1 Healthcare 8.27%
2 Energy 1.27%
3 Technology 0.21%
4 Communication Services 0.15%
5 Industrials 0.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
26
CALL
Bristol-Myers Squibb
BMY
$130B
$20.4M 0.75%
3,073
-6,400
-68% -$422K
LLY icon
27
PUT
Eli Lilly
LLY
$1.09T
$20.3M 0.74%
2,428
+2,268
+1,418% +$173K
IOC
28
PUT
DELISTED
Interoil Corporation
IOC
$20.2M 0.74%
3,356
+298
+10% +$15.2K
VTRS icon
29
CALL
Viatris
VTRS
$20.8B
$18.8M 0.69%
+2,777
New +$196K
MRK icon
30
Merck
MRK
$326B
$17.9M 0.65%
329,371
+160,953
+96% +$9.03M
PXD
31
PUT
DELISTED
Pioneer Natural Resource Co.
PXD
$17.1M 0.63%
+1,236
New +$196K
PRGO icon
32
CALL
Perrigo
PRGO
$1.43B
$17.1M 0.62%
925
+535
+137% +$102K
XNTK icon
33
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2B
$16.7M 0.61%
1,328
-646
-33% -$33.4K
EW icon
34
PUT
Edwards Lifesciences
EW
$48.2B
$16.6M 0.61%
+7,002
New +$158K
REGN icon
35
CALL
Regeneron Pharmaceuticals
REGN
$72.9B
$15.5M 0.57%
304
-802
-73% -$391K
BLUE
36
PUT
DELISTED
bluebird bio
BLUE
$15M 0.55%
69
+38
+123% +$77.4K
XOM icon
37
ExxonMobil
XOM
$634B
$14.8M 0.54%
+178,310
New +$15.3M
ALXN
38
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
$14.5M 0.53%
+804
New +$139K
LUMO
39
CALL
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$13.8M 0.5%
347
-102
-23% -$43.3K
MBLY
40
CALL
DELISTED
Mobileye N.V.
MBLY
$13.5M 0.49%
2,546
+2,415
+1,844% +$114K
RPTP
41
CALL
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$13.5M 0.49%
8,571
+6,028
+237% +$73.2K
RGLS
42
CALL
DELISTED
Regulus Therapeutics
RGLS
$12.9M 0.47%
98
– –
MDCO
43
CALL
DELISTED
Medicines Co
MDCO
$12.7M 0.46%
4,435
+4,217
+1,934% +$117K
MNKD icon
44
PUT
MannKind Corp
MNKD
$1.21B
$12.2M 0.45%
4,289
-321
-7% -$8.2K
TENX icon
45
CALL
Tenax Therapeutics
TENX
$419M
– –
0
– –
OPK icon
46
PUT
Opko Health
OPK
$1.23B
$12.1M 0.44%
7,496
+4,996
+200% +$77.7K
APC
47
PUT
DELISTED
Anadarko Petroleum
APC
$11.9M 0.43%
+1,523
New +$132K
MNK
48
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$11.5M 0.42%
980
+658
+204% +$81.1K
THOR
49
CALL
DELISTED
THORATEC CORPORATION
THOR
$11.1M 0.4%
2,486
+47
+2% +$2.06K
DVAX
50
CALL
DELISTED
Dynavax Technologies
DVAX
$10.6M 0.39%
+4,533
New +$98.7K
1
2
3 4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q2 2015 Portfolio in Review

As of Q2 2015, Sabby Management held 404 positions worth $2.74B, up 14% from $2.4B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Sabby Management withdrew a net $310M in Q2 2015, closing 88 positions and reducing 80 holdings. Its most notable exit was Allergan plc, an estimated $33.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 8.3% of assets, down from 9.4% a quarter earlier, followed by Energy and Technology.

Against the trend, Sabby Management opened a new position in ExxonMobil worth $14.8M.

  • Sabby Management's largest Q2 2015 buy was ExxonMobil: 178,310 shares worth $14.8M.
  • Sabby Management added most to iShares 20+ Year Treasury Bond ETF in Q2 2015, an estimated $23.4M increase.
  • Sabby Management's biggest Q2 2015 reduction was Tempest Therapeutics, cutting an estimated $53.9M.
  • Sabby Management fully exited Allergan plc in Q2 2015, selling an estimated $33.8M.
  • Sabby Management's ten largest holdings make up 45% of its $2.74B portfolio in Q2 2015.
  • Sabby Management opened 120 new positions and closed 88 in Q2 2015.
  • Sabby Management's portfolio value rose 14% quarter-over-quarter to $2.74B.

Based on Sabby Management's 13F filing for Q2 2015, filed 14 Aug 2015.